| 226.34 Delayed Data As of Oct 16 |  -2.29 / -1.00%Today’s Change | 136.44 Today|||52-Week Range 230.19 | +47.77% Year-to-Date |
| Zacks Value Trader Highlights: Exact Sciences, Edwards Lifesciences, Bristol Myers-Squibb, Occidental Petroleum and Exxon Mobil Sep 20 / Zacks.com - Paid Partner Content | Stock Investors: Do You Need a Late Cycle Plan? Sep 19 / Zacks.com - Paid Partner Content |
| What Makes Edwards Lifesciences (EW) a New Buy Stock Sep 20 / Zacks.com - Paid Partner Content |
| Previous close | 228.63 |
| Today’s open | 228.16 |
| Day’s range | 225.36 - 228.16 |
| Volume | 1,022,539 |
| Average volume (3 months) | 1,199,446 |
| Market cap | $47.3B |
| Earnings growth (last year) | +24.55% |
| Earnings growth (this year) | +13.70% |
| Earnings growth (next 5 years) | +11.67% |
| Revenue growth (last year) | +8.37% |
| P/E ratio | 66.2 |
| Price/Sales | 8.79 |
| Price/Book | 15.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | +2.03 | +0.38% |
| SNNSmith & Nephew PLC | +0.46 | +0.98% |
| SYKStryker Corp | +0.80 | +0.37% |
| STESteris plc | -0.70 | -0.49% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $1.22 |
| Annual revenue (last year) | $3.7B |
| Annual profit (last year) | $722.2M |
| Net profit margin | 19.40% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
